Acute Cellular Rejection Is a Risk Factor for Bronchiolitis Obliterans Syndrome Independent of Post-transplant Baseline FEV1

Journal of Heart and Lung Transplantation

Volumn 28, Issue 9, 2009, Pages 888-893

  Burton, Christopher M ^a,b   Iversen, Martin ^a   Carlsen, Jørn ^a   Mortensen, Jann ^b   Andersen, Claus B ^b   Steinbrüchel, Daniel ^b   Scheike, Thomas ^c  

^a Mental Health Services CPH   (Denmark)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; DACLIZUMAB; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG FIBROSIS; LUNG FUNCTION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADULT; BRONCHIOLITIS OBLITERANS; DEATH; FEMALE; FORCED EXPIRATORY VOLUME; GRAFT REJECTION; HEART-LUNG TRANSPLANTATION; HUMANS; INCIDENCE; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVORS; TIME FACTORS;

EID: 68949220837     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.04.022     Document Type: Article

References (24)

1. Estenne M., Maurer J.R., Boehler A., et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21 (2002) 297-310
2. Trulock E.P., Edwards L.B., Taylor D.O., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report-2006. J Heart Lung Transplant 25 (2006) 880-892
3. Burton C.M., Carlsen J., Mortensen J., et al. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome. J Heart Lung Transplant 26 (2007) 681-686
4. 1 and the development of bronchiolitis obliterans syndrome: an important confounder?. J Heart Lung Transplant 26 (2007) 1127-1134
5. Burton C.M., Milman N., Carlsen J., et al. The Copenhagen National Lung Transplant Group: survival after single lung, double lung, and heart-lung transplantation. J Heart Lung Transplant 24 (2005) 1834-1843
6. Burton C.M., Kristensen P., Lutzhoft R., et al. Cytomegalovirus infection in lung transplant patients: the role of prophylaxis and recipient-donor serotype matching. Scand J Infect Dis 38 (2006) 281-289
7. Burton C.M., Andersen C.B., Jensen A.S., et al. The incidence of acute cellular rejection after lung transplantation: a comparative study of anti-thymocyte globulin and daclizumab. J Heart Lung Transplant 25 (2006) 638-647
8. Iversen M., Burton C.M., Vand S., et al. Aspergillus infection in lung transplant patients: incidence and prognosis. Eur J Clin Microbiol Infect Dis 26 (2007) 879-886
9. Pintilie M. Competing risks: a practical perspective (2006), Wiley, New York
10. Burton C.M., Iversen M., Scheike T., et al. Minimal acute cellular rejection remains prevalent up to 2 years after lung transplantation: a retrospective analysis of 2697 transbronchial biopsies. Transplantation 85 (2008) 547-553
11. Bando K., Paradis I.L., Komatsu K., et al. Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation. J Thorac Cardiovasc Surg 109 (1995) 49-57
12. Girgis R.E., Tu I., Berry G.J., et al. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant 15 (1996) 1200-1208
13. Hopkins P.M., Aboyoun C.L., Chhajed P.N., et al., Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis. Am J Respir Crit Care Med 170 (2004) 1022-1026
14. Khalifah A.P., Hachem R.R., Chakinala M.M., et al. Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome. Am J Transplant 5 (2005) 2022-2030
15. Sundaresan S., Mohanakumar T., Smith M.A., et al. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation 65 (1998) 648-653
16. Swanson S.J., Mentzer S.J., Reilly J.J., et al. Surveillance transbronchial lung biopsies: implication for survival after lung transplantation. J Thorac Cardiovasc Surg 119 (2000) 27-37
17. El-Gamel A., Sim E., Hasleton P., et al. Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant 18 (1999) 828-837
18. Heng D., Sharples L.D., McNeil K., et al. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant 17 (1998) 1255-1263
19. Keller C.A., Cagle P.T., Brown R.W., et al. Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation. Chest 107 (1995) 973-980
20. Kroshus T.J., Kshettry V.R., Savik K., et al. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 114 (1997) 195-202
21. Husain A.N., Siddiqui M.T., Holmes E.W., et al. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 159 (1999) 829-833
22. Sharples L.D., McNeil K., Stewart S., et al. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 21 (2002) 271-281
23. Sato M., Gutierrez C., Waddell T.K., et al. Donor-recipient gender mismatch in lung transplantation: impact on obliterative bronchiolitis and survival. J Heart Lung Transplant 24 (2005) 2000-2001
24. Roberts D.H., Wain J.C., Chang Y., et al. Donor-recipient gender mismatch in lung transplantation: impact on obliterative bronchiolitis and survival. J Heart Lung Transplant 23 (2004) 1252-1259